Invention Grant
- Patent Title: Compositions and methods for C. difficile treatment
-
Application No.: US16313791Application Date: 2017-07-03
-
Publication No.: US10849936B2Publication Date: 2020-12-01
- Inventor: Matthew J. Hamilton , Alexander Khoruts , Michael J. Sadowsky , Christopher M. Staley
- Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
- Applicant Address: US MN Minneapolis
- Assignee: Regents of the University of Minnesota
- Current Assignee: Regents of the University of Minnesota
- Current Assignee Address: US MN Minneapolis
- Agency: Arnold & Porter Kaye Scholer LLP
- International Application: PCT/US2017/040591 WO 20170703
- International Announcement: WO2018/006088 WO 20180104
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A61K9/00 ; A61P31/04 ; A61K9/19 ; A61K31/43 ; A61K9/16 ; A61K9/20 ; A01N1/02
Abstract:
The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
Public/Granted literature
- US20190247445A1 COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT Public/Granted day:2019-08-15
Information query
